MetLife, Inc. is projected to rise to $115.30 by 2027, a +26% move from its current price of $91.65. MET is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $90.40 | $91.65 | $92.91 | 0.00% |
| Jul 14 | $89.89 | $91.65 | $93.44 | 0.00% |
| Jul 15 | $89.49 | $91.65 | $93.85 | 0.00% |
| Jul 16 | $89.17 | $91.65 | $94.19 | -0.01% |
| Jul 17 | $88.88 | $91.64 | $94.50 | -0.01% |
| Jul 18 | $88.61 | $91.64 | $94.77 | -0.01% |
| Jul 19 | $88.38 | $91.64 | $95.03 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $88.38 | $91.64 | $95.03 | -0.01% |
| Week 2 | $87.05 | $91.63 | $96.46 | -0.02% |
| Week 3 | $86.04 | $91.63 | $97.57 | -0.03% |
| Week 4 | $85.20 | $91.62 | $98.51 | -0.04% |
| Week 5 | $84.47 | $91.61 | $99.35 | -0.04% |
| Week 6 | $83.81 | $91.60 | $100.12 | -0.05% |
| Week 7 | $83.21 | $91.59 | $100.82 | -0.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MetLife, Inc. is a financial services company that provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings.
The company offers life, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. In addition, it offers pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. The company was incorporated in 1999 and is based in New York, New York.
MetLife, Inc. (MET) is a financial services company with a current price of $87.56 and a market capitalization of $56.34B, ranking 276. It operates across multiple segments including Group Benefits, Retirement and Income Solutions, and regional operations in Asia, Latin America, and EMEA, plus MetLife Holdings.
The near-term forecast for 2026 shows an average price of $87.56 with a neutral sentiment, a low of $67.70 and a high of $110.72.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 11.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 7.8% above — clearing it would confirm fresh momentum.
Key MET support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MET market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $91.01 | Buy | $90.67 | Buy |
| MA 10 | $88.88 | Buy | $89.48 | Buy |
| MA 20 | $87.83 | Buy | $87.88 | Buy |
| MA 50 | $83.99 | Buy | $84.41 | Buy |
| MA 100 | $78.64 | Buy | $81.47 | Buy |
| MA 200 | $78.76 | Buy | $79.70 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.42 | Neutral |
| Stoch RSI (14) | 84.59 | Sell |
| CCI (20) | 131.79 | Buy |
| Williams %R (14) | -0.28 | Info |
| MACD (12,26,9) | 0.32 | Buy |
| ROC (12) | 4.11 | Buy |
| Bollinger %B (20,2) | 0.91 | Neutral |
| Stochastic %K (14) | 99.72 | Sell |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 4.96 | Buy |
| Ultimate (7,14,28) | 76.25 | Sell |
| Momentum (10) | 7.02 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 92.09 | Sell |
| ADX (14) | 24.02 | Buy |
| ATR (14) | 1.17 | Info |
The 30-day technical picture is labeled BULLISH with an RSI(14) of 60. The chart shows a SMA50 of $81.07 and a SMA200 of $78.22, with a support level at $77.98 and a resistance at $88.84. The 30-day range runs from a low of $81.01 to a high of $94.64, highlighting a constructive but contained momentum over the recent month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $67.70 | $91.65 | $115.57 | 0% | Neutral | |
| $94.43 | $115.30 | $147.18 | +26% | Bullish | |
| $113.52 | $141.21 | $185.13 | +54% | Bullish | |
| $135.53 | $171.18 | $229.21 | +87% | Bullish | |
| $151.69 | $194.19 | $264.70 | +112% | Bullish | |
| $168.73 | $218.64 | $302.74 | +139% | Bullish | |
| $180.68 | $236.77 | $332.51 | +158% | Bullish | |
| $188.95 | $250.22 | $355.94 | +173% | Bullish | |
| $221.24 | $295.89 | $425.94 | +223% | Bullish | |
| $260.23 | $351.34 | $511.39 | +283% | Bullish | |
| $369.99 | $521.00 | $794.71 | +468% | Bullish | |
| $769.70 | $1,162.42 | $1,900.65 | +11.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $67.70 | $91.65 | $109.43 | +0.00% |
| August 2026 | $78.07 | $91.38 | $109.27 | -0.29% |
| September 2026 | $77.83 | $91.54 | $110.32 | +0.18% |
| October 2026 | $79.77 | $94.21 | $114.29 | +2.91% |
| November 2026 | $80.03 | $94.84 | $115.69 | +0.67% |
| December 2026 | $79.29 | $94.27 | $115.57 | -0.61% |
Click any year to see its month-by-month MET forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MET price prediction for 2026 points to an average of $91.65 (low $67.70, high $115.57) — a potential gain of 0% on today's $91.65. A consolidation phase looks the most probable path here.
In 2027, MET is projected to trade between $94.43 and $147.18, averaging $115.30 — a potential gain of +26% from today's $91.65. That is up +26% on the projected 2026 average. Momentum favours further upside here.
MetLife, Inc.'s 2028 outlook centres on $141.21, within a $113.52 to $185.13 range. That is up +22% on the projected 2027 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, MET could reach as high as $229.21, with a base case around $171.18 and support toward $135.53 — roughly +87% from $91.65. Momentum favours further upside here.
Expect MET to range from $151.69 to $264.70 through 2030. The $194.19 average target implies a +112% move from current prices. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The MET price prediction for 2031 points to an average of $218.64 (low $168.73, high $302.74) — a potential gain of +139% on today's $91.65. Momentum favours further upside here.
In 2032, MET is projected to trade between $180.68 and $332.51, averaging $236.77 — a potential gain of +158% from today's $91.65. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
MetLife, Inc.'s 2033 outlook centres on $250.22, within a $188.95 to $355.94 range. That is up +6% on the projected 2032 average. That marks a +173% change versus current levels. Momentum favours further upside here.
By 2034, MET could reach as high as $425.94, with a base case around $295.89 and support toward $221.24 — roughly +223% from $91.65. Buyers look set to stay in control over this stretch.
Expect MET to range from $260.23 to $511.39 through 2035. The $351.34 average target implies a +283% move from current prices. That is up +19% on the projected 2034 average. Momentum favours further upside here.
The MET price prediction for 2040 points to an average of $521.00 (low $369.99, high $794.71) — a potential gain of +468% on today's $91.65. Buyers look set to stay in control over this stretch.
In 2050, MET is projected to trade between $769.70 and $1,900.65, averaging $1,162.42 — a potential gain of +11.7x from today's $91.65. That is up +123% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MET today (≈ 10.911075 MET) could be worth
$12,683.29
+$11,683.29 (+1168%) by 2050 · US Dollar
Based on the average projected MET price of $1,162.42 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in METwould be worth at today's price.
$1,000 invested in MET on Jul 10, 2025 (≈ 12.759984 MET) would be worth
$1,169.45
+$169.45 (+16.9%) today · 1.17× · US Dollar
Based on a MET entry price of $78.37 vs. today's $91.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $90.06 | $1,017.65 | +1.8% |
| 1 month ago | $86.13 | $1,064.09 | +6.4% |
| 3 months ago | $73.88 | $1,240.53 | +24.1% |
| 6 months ago | $78.32 | $1,170.2 | +17.0% |
| 1 year ago | $78.37 | $1,169.45 | +16.9% |
| All time (5.0y) ago | $58.68 | $1,561.86 | +56.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MET forecast.
Our base-case forecast reaches $180.00 around 2030.
Implied market cap at $180.00: $115.82B
The multi-year forecast depicts a bullish trajectory after 2026. In 2027, the average price is $108.60 with a min of $88.85 and a max of $138.86 and a projected ROI of 24; sentiment is BULLISH. By 2028, the average rises to $125.88 (min $101.11, max $165.24; ROI 43.8).
In 2029, the average is $153.40 (min $121.35, max $205.60; ROI 75.2) and 2030 shows an average of $174.10 (min $135.91, max $237.53; ROI 98.8), with continued bullish sentiment. For 2031–2035 the outlook remains bullish with rising averages and higher ROIs, culminating in 2040 an average of $409.55 (min $290.73, max $624.98; ROI 367.7) and 2050 an average of $909.13 (min $601.79, max $1,486.96; ROI 938.3). These are estimates, not guarantees, and reflect potential upside under the given assumptions.
The forecast highlights strong long-term upside with meaningful compounding potential but acknowledges the inherent uncertainty in future price outcomes.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $174.10 with a min of $135.91 and a max of $237.53, and a ROI of 98.8%; sentiment is BULLISH.
The forecast indicates bullish sentiment from 2027 onward with rising average prices: 2027 avg $108.60 (ROI 24), 2028 avg $125.88 (ROI 43.8), 2029 avg $153.40 (ROI 75.2), and 2030 avg $174.10 (ROI 98.8). 2026 is neutral with avg $87.56.
Yes. The 2027 forecast shows an average price of $108.60, which is above $100.
Current price is $87.56 and market cap is $56.34B; the rank is 276.
The forecast max by 2050 is $1,486.96 with an average of $909.13 and a ROI of 938.3; sentiment is BULLISH.
MetLife, Inc. Community Discussion
0Share your MetLife, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.